These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25795602)

  • 1. Maintenance of access as demand for substance use disorder treatment grows.
    Frakt AB; Trafton J; Pizer SD
    J Subst Abuse Treat; 2015 Aug; 55():58-63. PubMed ID: 25795602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Directed funding to address under-provision of treatment for substance use disorders: a quantitative study.
    Frakt AB; Trafton J; Wallace A; Neuman M; Pizer S
    Implement Sci; 2013 Jul; 8():79. PubMed ID: 23866119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.
    Ellerbe LS; Manfredi L; Gupta S; Phelps TE; Bowe TR; Rubinsky AD; Burden JL; Harris AH
    Addict Sci Clin Pract; 2017 Apr; 12(1):10. PubMed ID: 28372579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Improvements in Measured Performance Driven by Better Treatment or "Denominator Management"?
    Harris AH; Chen C; Rubinsky AD; Hoggatt KJ; Neuman M; Vanneman ME
    J Gen Intern Med; 2016 Apr; 31 Suppl 1(Suppl 1):21-7. PubMed ID: 26951270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in service utilization among Operations Enduring Freedom, Iraqi Freedom, and New Dawn Veterans Affairs patients with severe mental illness and substance use disorders.
    Painter JM; Brignone E; Gilmore AK; Lehavot K; Fargo J; Suo Y; Simpson T; Carter ME; Blais RK; Gundlapalli AV
    Psychol Serv; 2018 Feb; 15(1):11-20. PubMed ID: 28517950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving PTSD/substance abuse treatment in the VA: a survey of providers.
    Najavits LM; Norman SB; Kivlahan D; Kosten TR
    Am J Addict; 2010; 19(3):257-63. PubMed ID: 20525033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Special Services for Women in Substance Use Disorders Treatment: How Does the Department of Veterans Affairs Compare with Other Providers?
    Heslin KC; Gable A; Dobalian A
    Womens Health Issues; 2015; 25(6):666-72. PubMed ID: 26329259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. If substance use disorder treatment more than offsets its costs, why don't more medical centers want to provide it? A budget impact analysis in the Veterans Health Administration.
    Humphreys K; Wagner TH; Gage M
    J Subst Abuse Treat; 2011 Oct; 41(3):243-51. PubMed ID: 21664790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance Use Disorder Treatment Services for Women in the Veterans Health Administration.
    Timko C; Hoggatt KJ; Wu FM; Tjemsland A; Cucciare M; Rubin A; Simpson TL
    Womens Health Issues; 2017; 27(6):639-645. PubMed ID: 28602581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High inpatient utilization among Veterans Health Administration patients with substance-use disorders and co-occurring mental health conditions.
    Painter JM; Malte CA; Rubinsky AD; Campellone TR; Gilmore AK; Baer JS; Hawkins EJ
    Am J Drug Alcohol Abuse; 2018; 44(3):386-394. PubMed ID: 29095057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of VA and Medicare services by dually eligible veterans with psychiatric problems.
    Carey K; Montez-Rath ME; Rosen AK; Christiansen CL; Loveland S; Ettner SL
    Health Serv Res; 2008 Aug; 43(4):1164-83. PubMed ID: 18355256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Impacting Perceived Access to Early Prenatal Care among Pregnant Veterans Enrolled in the Department of Veterans Affairs.
    Mattocks KM; Baldor R; Bean-Mayberry B; Cucciare M; Gerber MR; Goldstein KM; Hammer KD; Hill EE; Kroll-Desrosiers A; Prochazka AV; Sadler AG; Bastian L
    Womens Health Issues; 2019; 29(1):56-63. PubMed ID: 30446330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fiscal strain and access to opiate substitution therapy at Department of Veterans Affairs Medical Centers.
    Rosenheck R; Leslie D; Woody G
    Am J Addict; 2003; 12(3):220-8. PubMed ID: 12851018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans.
    Kraemer KL; McGinnis KA; Fiellin DA; Skanderson M; Gordon AJ; Robbins J; Zickmund S; Bryant K; Korthuis PT
    J Subst Abuse Treat; 2019 Aug; 103():23-32. PubMed ID: 31229189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Payer shifting after expansions in access to private care among veterans.
    Rose L; Tran D; Wu S; Dalton A; Kirsh S; Vashi A
    Health Serv Res; 2023 Dec; 58(6):1189-1197. PubMed ID: 37076113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staff Perceptions of Substance Use Disorder Treatment in VA Primary Care-Mental Health Integrated Clinics.
    Zubkoff L; Shiner B; Watts BV
    J Subst Abuse Treat; 2016 Nov; 70():44-49. PubMed ID: 27692187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to VA services for returning veterans with PTSD.
    Shiner B; Drake RE; Watts BV; Desai RA; Schnurr PP
    Mil Med; 2012 Jul; 177(7):814-22. PubMed ID: 22808888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient continuing care after residential substance use disorder treatment in the US Veterans Health Administration: Facilitators and challenges.
    Rubinsky AD; Ellerbe LS; Gupta S; Phelps TE; Bowe T; Burden JL; Harris AHS
    Subst Abus; 2018; 39(3):322-330. PubMed ID: 29043947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and service utilization of homeless veterans entering VA substance use treatment.
    Cox KB; Malte CA; Saxon AJ
    Psychol Serv; 2017 May; 14(2):208-213. PubMed ID: 28481606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of VA Payment Reform for Dialysis with Spending, Access to Care, and Outcomes for Veterans with ESKD.
    Wang V; Swaminathan S; Corneau EA; Maciejewski ML; Trivedi AN; O'Hare AM; Mor V
    Clin J Am Soc Nephrol; 2020 Nov; 15(11):1631-1639. PubMed ID: 32963019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.